PVLA
PALVELLA THERAPEUTICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$122.96
+2.21%Next report
Analyst consensus
- Next report date
- Nov 10, 2026
- EPS estimate
- -$1.79
- Revenue estimate
- $16.7K
Latest reported
- Last report date
- Aug 4, 2026
- EPS actual
- -$1.52
- EPS estimate
- -$1.17
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -25.7%
- Revenue beats (12Q)
- 2
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $243
- PT range
- $240 – $246
- Analysts
- 3
3 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 4, 2026 | -$1.17 | -$1.52 | Miss -29.91% | — |
| May 7, 2026 | -$0.90 | -$1.20 | Miss -33.33% | — |
| Mar 31, 2026 | -$0.91 | -$1.08 | Miss -18.53% | — |
| Nov 11, 2025 | -$0.85 | -$1.03 | Miss -21.18% | — |
| Aug 14, 2025 | -$0.78 | -$0.86 | Miss -10.26% | — |
| May 15, 2025 | -$3.40 | -$0.74 | Beat 78.24% | — |
| Mar 31, 2025 | -$0.39 | $4.00 | Beat 1125.64% | — |
| Aug 14, 2024 | -$2.40 | -$2.76 | Miss -15.00% | — |
| May 15, 2024 | -$4.80 | -$2.00 | Beat 58.33% | — |
| Nov 14, 2023 | -$8.80 | -$8.70 | Beat 1.15% | $19.5M |
| Aug 10, 2023 | -$13 | $3.62 | Beat 128.88% | $20.1M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 10, 2026